JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2005; 46:1473-1478, doi:10.1016/j.jacc.2005.06.070 (Published online 22 September 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaber, W. A.
Right arrow Articles by Rihal, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaber, W. A.
Right arrow Articles by Rihal, C. S.

Application of Evidence-Based Medical Therapy Is Associated With Improved Outcomes After Percutaneous Coronary Intervention and Is a Valid Quality Indicator

Wissam A. Jaber, MD, Ryan J. Lennon, MS, Verghese Mathew, MD, David R. Holmes, Jr, MD, Amir Lerman, MD and Charanjit S. Rihal, MD, MBA*

Mayo Clinic, Rochester, Minnesota



View larger version (15K):

[in a new window]
  		Figure 1 Kaplan-Meier curve for adjusted myocardial infarction-free survival according to medication score (MEDS). Relative to MEDS 0 to 1 curve, the p values for MEDS 2, 3, and 4 curves are 0.15, 0.006, and 0.002, respectively. The numbers below the curves are the number of patients at risk for each year of follow-up.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.